Inspur Electronic Information Showcases Industry-Leading Server Solutions and Applications for Intelligent Manufacturing Transformation at Hannover Messe 2023
Inspur Electronic Information, a leading IT infrastructure solutions provider, will attend Hannover Messe 2023 from April 17-21. With a main theme of “Intelligent IT transformation for Manufacturing,” the company will bring its latest and innovative G7 server family, liquid cooling servers, and edge servers that support recent customer cases in manufacturing and drive the digitalization of manufacturing customers throughout Europe.
Inspur Electronic Information will join around 4,000 companies from the mechanical engineering, electrical, and digital industries. Industry leaders would gather to share their insights on topics including digital platform, cloud & infrastrucuture, and digital energy & energy efficiency.
Inspur Electronic Information believes that the digitization and optimization of manufacturing is the first step of Industry 4.0, a process where traditional enterprises constantly introduce digital and intelligent technologies and conduct production technology and model innovations based on those technologies in production. This deepens the digital and intelligent integration of supply chain, warehouse, manufacturing, quality control, logistics, delivery, service and other links. Therefore, manufacturing enterprises need a stable, reliable, efficient, green, and dynamically scalable IT infrastructure that can provide trusted business assurance, cost efficiency, and adaptability.
G7 server family, liquid cooling and edge hardware for intelligent manufacturing applications
Inspur Electronic Information has industry-leading computing platform solutions and expansive deployment experiences. At Hannover Messe 2023, the company will bring G7 servers, liquid cooling servers, and edge servers with the newest improvement in reliability, flexibility and sustainability. These products meet computing requirements in different environments and scenarios, such as data center and edge, and provide manufacturing enterprises with reliable, flexible, and efficient intelligent manufacturing IT architecture solutions.
The latest G7 server family will be the highlight at the exhibit, with NF5266G7, NF5280G7, and NF5688G7 making an appearance. The G7 platform delivers an 86% computing performance improvement compared to the previous-generation. G7 server management module, memory module, network module, and other modules are designed based on open standards and compatible with DC-SCM management module. The open design further improves flexible scalability of the systems. The G7 platform offers reliability from firmware to hardware. Core components such as power supply, BIOS, and BMC adopt full redundancy design. Up to 95% fault diagnosis accuracy is achieved through cloud operation and maintenance. The G7 platform can be equipped with liquid cooling to lower the PUE as low as 1.1 and features excellent flexibility, energy-savings, and reliability, better facilitating the key applications for intelligent manufacturing transformation.
- NF5280G7 is a datacenter full-scene adaptable rack server that has flexible PCle expansion with OCP NIC 3.0 slots and 4 dual-width GPUs. It is especially suitable for ERP, CRM, MES, WMS, and other intelligent manufacturing scenarios, as well as small and medium-sized databases, big data analysis, and other intelligent manufacturing key systems, both on-premise and cloud deployment.
- NF5688G7 is the next-gen AI training server suitable for the most demanding industry design and intelligent manufacturing tasks, like the trillion-parameter Transformer model training. It supports eight 700w GPUs and flexible PCIe extensions using CX7, OCP3.0, and SmartNICs, delivering industry-leading performance, I/O expansion, and energy efficiency.
- The high-density storage server NF5266G7 features a three-tier storage architecture to optimize balance between computing and storage I/O capabilities. It is highly suitable for data analytics, data archive, video storage and processing, cloud storage pool, and other application scenarios in the manufacturing industry.
Carbon reduction in manufacturing is also an important requirement in the era of Industry 4.0. Inspur Electronic Information has increased its push for energy consumption reduction in data centers by launching full-stack liquid-cooled server solutions, helping users fulfill their sustainable development goals. Representing the company’s liquid cooling lineup will be the high-density multi-node server i24LM6 that will be showcased on-site. This system can adapt to various environments, including high temperatures and high altitudes, and provides exceptional cooling performance for CPUs with high power consumption. With warm-water cooling technology and a CPU+VR+DIMM liquid-cooling plate, it has a PUE below 1.1, which significantly reduces cooling costs.
The amount of data being generated and the amount of data requiring processing on edge is increasing exponentially. Inspur Electronic Information has developed a comprehensive edge server portfolio featuring outstanding performance, great environmental adaptability, and flexible scalability, to support the development of Industry 4.0 from cloud, edge, and data centers. EIS200, which will be displayed on site, is a lightweight edge AI computing product, providing edge computing power up to 21TOPS while only consuming 25W. The system is suitable for industrial quality inspection and other scenarios.
Deep Technology Integration to Transform the Manufacturing Industry
Inspur Electronic Information has long supported the manufacturing industry and has provided computing technologies for automotive design and simulation, automotive manufacturing, operation and maintenance management, and more for top European automotive manufacturers. It recently provided an HPC as a Service (HPCaaS) solution for computer-aided engineering (CAE) to an auto manufacturer in Europe, together with NEC Deutschland. The joint solution offers largely-enhanced HPC performance with low power consumption and TCO, accelerating the manufacturer along the path towards digitalization and industry upgrade.
When: 17-21 April, 2023
Where: Hannover Messegelände, Germany, Hall 14, Stand #J61.
About Inspur Electronic Information
Founded in 1998, Inspur Electronic Information Industry Co Ltd is the world's leading provider of IT infrastructure products, solutions, and services. Its business focuses on three major fields: servers, storage and networks. It has 8 R&D centers, 10 production bases, and 26 branches covering more than 120 countries and regions. Inspur Electronic Information is committed to the innovation of digital technology along with the application and integration of digital worlds with the physical world. It is helping enterprises embark on a path of sustainable development by driving intelligent digital transformation. To learn more, visit https://www.ieisystem.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230414005115/en/
Contact information
Fiona Liu
Inspur Electronic Information
liuxuan01@ieisystem.com
Constanze Kreil
Allison+Partners
constanze.kreil@allisonpr.com
+49 (0)151 210 289 97
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release
I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 10:00:00 EET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA ® Commercialization in Central and Eastern Europe7.1.2026 09:30:00 EET | Press release
Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnosed FLT3-ITD positive AML in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, and as maintenance monotherap
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom